Sort
21,281 grants matching “influenza”
Accelerator for the rapid development of countermeasures targeting drug resistant fungal pathogens
$6,977,446Arturo Casadevall · Johns Hopkins University · U19 · FY2025 · AI
MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESOURCE REPOSITORY (MID-BRR)
$6,917,308Timothy T Stedman · American Type Culture Collection · N01 · FY2012 · AI
Vaccine Immunology Program
$6,901,965Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE
$6,899,386Emmanuel Walter · Duke University · N01 · FY2020 · AI
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated heart failure (INVESTED)
$6,828,478Scott David Solomon · Brigham And Women'S Hospital · U01 · FY2018 · HL
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$6,820,430Mark Joseph Mulligan · New York University School Of Medicine · UM1 · FY2021 · AI
Administrative Core
$6,781,491Sumit K Chanda · Scripps Research Institute, The · U19 · FY2022 · AI
Novel Innate Immune Adjuvant for Avian Influenza and West Nile Virus Vaccines
$6,770,054Michael Gale · University Of Washington · N01 · FY2013 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$6,633,364Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2016 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS
$6,620,891Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2020 · AI
Centers of Excellence for Influenza Research and Surveillance
$6,618,636Richard Compans · Emory University · N01 · FY2012 · AI
Antiviral Drug Discovery and Development Center - Overall
$6,606,164Richard J. Whitley · University Of Alabama At Birmingham · U19 · FY2015 · AI
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
$6,588,156Gregory A. Poland · Mayo Clinic Rochester · U01 · FY2013 · AI
NIAID Centers of Excellence for Influenza Research and Response
$6,585,950Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2025 · AI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission
$6,531,361Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Centers of Excellence for Influenza Research and Surveillance
$6,496,353Adolpho Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2012 · AI
Alphavirus Replicon Vaccines against Influenza
$6,490,848Alphavax Human Vaccines, Inc. · UC1 · FY2005 · AI
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
$6,450,971Gregory A. Poland · Mayo Clinic Rochester · U01 · FY2011 · AI
Modeling Host Responses to Understand Severe Human Virus Infections
$6,428,344Yoshihiro Kawaoka · University Of Wisconsin-Madison · U19 · FY2016 · AI
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH ACTIVITIES
$6,428,100Scott Hensley · University Of Pennsylvania · N01 · FY2023 · AI
Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)
$6,390,081Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr · UM1 · FY2020 · AI
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE
$6,379,531Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2022 · AI
Establishment of a Vaccine Pilot Plant
$6,376,856Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2012 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$6,372,793David S Stephens · Emory University · UM1 · FY2021 · AI
Systems Approach to Immunity and Inflammation
$6,357,746Richard J Ulevitch · Scripps Research Institute, The · U19 · FY2012 · AI